T1	Non-representable 0 46	Therapy area located outside of head and neck;
T2	Condition 54 67	skin diseases
T3	Qualifier 79 117	interfere with the efficacy evaluation
R1	Has_qualifier Arg1:T2 Arg2:T3	
T4	Drug 157 164	isotope
T5	Drug 168 171	PDT
T6	Procedure 181 190	treatment
T7	Qualifier 197 241	might interfere with the efficacy evaluation
R2	Has_qualifier Arg1:T6 Arg2:T7	
*	OR T5 T4
T8	Scope 157 171	isotope or PDT
R3	Has_scope Arg1:T6 Arg2:T8	
T9	Condition 244 251	Allergy
T10	Drug 255 265	porphyrins
T11	Condition 281 297	Photosensitivity
T12	Drug 270 279	analogues
T13	Condition 299 308	Porphyria
T14	Condition 310 331	Allergic constitution
*	OR T13 T14 T11
*	OR T10 T12
T15	Scope 255 279	porphyrins and analogues
R4	Has_scope Arg1:T9 Arg2:T15	
T16	Condition 334 348	Scar diathesis
T17	Condition 351 379	Immunocompromised conditions
T18	Condition 382 416	Electrocardiographic abnormalities
T19	Qualifier 420 427	organic
T20	Condition 428 442	heart diseases
R5	Has_qualifier Arg1:T20 Arg2:T19	
T21	Procedure 382 402	Electrocardiographic
R6	multi Arg1:T18 Arg2:T21	
*	OR T18 T20
T22	Condition 445 466	Coagulation disorders
T23	Measurement 469 476;486 495	Hepatic functions
T24	Measurement 480 495	renal functions
T25	Value 496 504	abnormal
R7	Has_value Arg1:T23 Arg2:T25	
R8	Has_value Arg1:T24 Arg2:T25	
*	OR T23 T24
T26	Measurement 506 530	alanine aminotransferase
T27	Measurement 534 556	aspartate transaminase
T28	Measurement 560 575	total bilirubin
*	OR T26 T27 T28
T29	Value 576 609	> 1.5 upper limit of normal [ULN]
T30	Scope 506 575	alanine aminotransferase or aspartate transaminase or total bilirubin
R9	Has_value Arg1:T30 Arg2:T29	
T31	Measurement 614 630	serum creatinine
T32	Measurement 634 653	blood urea nitrogen
T33	Value 654 663	> 1.5 ULN
*	OR T31 T32
T34	Scope 614 653	serum creatinine or blood urea nitrogen
R10	Has_value Arg1:T34 Arg2:T33	
*	OR T30 T34
T35	Scope 506 663	alanine aminotransferase or aspartate transaminase or total bilirubin > 1.5 upper limit of normal [ULN], or serum creatinine or blood urea nitrogen > 1.5 ULN
T36	Scope 469 504	Hepatic or renal functions abnormal
R11	Subsumes Arg1:T36 Arg2:T35	
T37	Condition 667 687	Psychiatric diseases
T38	Qualifier 689 695	Severe
T39	Condition 696 712	endocrinopathies
R12	Has_qualifier Arg1:T39 Arg2:T38	
T40	Temporal 715 723	Previous
T41	Procedure 724 731	therapy
T42	Temporal 739 762	within the last 4 weeks
R13	Has_temporal Arg1:T41 Arg2:T40	
R14	Has_temporal Arg1:T41 Arg2:T42	
T43	Observation 765 802	Participation in any clinical studies
T44	Temporal 803 826	within the last 4 weeks
R15	Has_temporal Arg1:T43 Arg2:T44	
T45	Non-query-able 829 897	Be judged not suitable to participate the study by the investigators
T46	Condition 735 738	PWS
R16	AND Arg1:T41 Arg2:T46	
